Ardelyx (ARDX) Net Margin (2013 - 2026)

Ardelyx (ARDX) reported Net Margin of 39.81% for Q1 2026, up 1571.0% on a YoY basis from 2.38% in Q1 2025, and down 12146.16% quarter-over-quarter from 0.33% in Q4 2025.

Ardelyx (ARDX) Net Margin (2013 - 2026) Analysis & Trends

Ardelyx has reported Net Margin for 12 years, with the latest figure at 39.81% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 1571.0% year-over-year to 39.81%; the trailing twelve-month figure through Mar 2026 stood at 18.1% (down 324.0% YoY), and the FY2025 full-year result was 15.12%, down 339.0% from the prior year.
  • Net Margin for Q1 2026 stood at 39.81%, down from 0.33% in the prior quarter.
  • The five-year high for Net Margin was 24.21% in Q4 2022, with the low at 5998.08% in Q1 2022.
  • Historically, Net Margin has averaged 476.72% across 5 years, with a median of 39.81% in 2026.
  • Annual changes were most pronounced in 2022 — Net Margin slumped 549435 bps — and 2023, when it jumped 576259 bps.
  • Ardelyx's Net Margin stood at 24.21% in 2022, then plunged by 446 bps to 83.82% in 2023, then surged by 105 bps to 4.0% in 2024, then plunged by 108 bps to 0.33% in 2025, then plunged by 12146 bps to 39.81% in 2026.
  • The last three Net Margin figures came in at 39.81% (Q1 2026), 0.33% (Q4 2025), and 28.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn -39.81%

Historic Data

Download Data
DateValue
Mar 31, 2026 -39.81%
Dec 31, 2025 -0.33%
Sep 30, 2025 -28.50%
Jun 30, 2025 -19.54%
Mar 31, 2025 -55.51%
Dec 31, 2024 4.00%
Sep 30, 2024 -0.82%
Jun 30, 2024 -22.47%
Mar 31, 2024 -57.62%
Dec 31, 2023 -83.82%
Sep 30, 2023 11.76%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.49%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.43%
Mar 31, 2022 -5,998.08%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.86%
Jun 30, 2021 -3,441.66%